Comparison between the Originator and Me-too Drugs of First- Generation EGFR-TKI in EGFR-Mutant NSCLC Patients: A Retrospective Cohort Study

Evania Nakhwah Saraswati

doi:https://doi.org/10.47119/IJRP1001471420246349